AzTrials
AzTrials

Colorectal CarcinomaNCT06686953

The Effect of Environmental Pollution on Colorectal Cancer

An observational study of Colorectal Carcinoma, run by Dong Peng.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Colorectal cancer (CRC) is one of the most common malignancies worldwide, and its main risk factors include age, genetic factors, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn's disease), unhealthy diets (e.g., high-fat, low-fibre diets), obesity, physical inactivity, smoking, and excessive alcohol… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colorectal Carcinoma
How many people
6,300 participants
Where
No sites listed yet
Study dates
1 Jan 2010to 1 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients diagnosed as colorectal cancer

Who may be able to join

  • age ≥18 years;
  • patients diagnosed with colorectal cancer by pathological biopsy before surgery;
  • patients did not undergo chemotherapy, radiotherapy, targeted and immunotherapy, etc. before enrolment;
  • willing to participate in this study and sign an informed consent form;
  • complete clinical data.

Who cannot join

  • patients with primary malignant tumours other than colorectal cancer;
  • patients with systemic diseases, such as severe cardiopulmonary insufficiency, that affect the choice of treatment options;
  • patients who are not suitable for enrolment as assessed by the investigator;
  • incomplete clinical data.

About this study

Official title: Clinical Study of the Effect of Environmental Pollution on the Prognosis of Colorectal Cancer.

Colorectal cancer (CRC) is one of the most common malignancies worldwide, and its main risk factors include age, genetic factors, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn's disease), unhealthy diets (e.g., high-fat, low-fibre diets), obesity, physical inactivity, smoking, and excessive alcohol consumption. The relationship between environmental pollution and colorectal cancer has received increasing attention in recent years. Studies have shown that long-term exposure to fine particulate matter in the air, such as passive smoking, soot and oil smoke exposure, incense burning exposure, occupational exposure and outdoor work, PM2.5, PM10 and NO2 may increase the risk of colorectal cancer. These particulate matter can enter the lungs through breathing and trigger a chronic inflammatory response in the systemic system, thus increasing the risk of cancer development. This study intends to determine the extent of air pollution's impact on colorectal cancer prognosis by analysing survival data of colorectal cancer patients in regions with different pollution levels. As well as to investigate the association between air pollution levels and postoperative recurrence in colorectal cancer patients, looking for possible mechanisms.

Keywords
colorectal cancer, environment, airpollution, greenness
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06686953
Study groupRoleWhat they receive
the colorectal cancer grouppatients diagnosed as colorectal cancer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. colorectal cancer

    the time for diagnosing colorectal cancer

    Measured: From 18 years old until the developing colorectal cancer, through study completion, an average of 5 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2024
  2. Study start1 Jan 2010
  3. Primary completion1 Nov 2024
  4. Study completion1 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
6,300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06686953
Sponsor's protocol ID
ZZ2024-291-01
Status last verified
Nov 2024
First submitted
12 Nov 2024
Last updated
13 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Clinical centres conducting this study are not allowed to disclose patient information and data sharing.

Questions about this trial

What is this clinical trial studying?

An observational study of Colorectal Carcinoma, run by Dong Peng.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

colorectal cancer (time frame: From 18 years old until the developing colorectal cancer, through study completion, an average of 5 year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in